文献速递头颈部肿瘤放疗

头颈癌放疗相关皮炎、口干、黏膜炎和吞咽困难的预测性生物标志物:一项系统综述

Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review.
PubMed 文献 · Radiother Oncol · 2024-12-18

本系统综述检索EMBASE和PubMed 2010至2023年文献,纳入69篇出版物,评估头颈癌放疗相关皮炎、黏膜炎、黏稠唾液/口干和吞咽困难的预测性生物标志物。最常研究的生物标志物为DNA单核苷酸多态性(SNPs,59%)、唾液蛋白(13%)和细菌(10%),在低偏倚出版物中鉴定出10个有统计学意义的生物标志物(均为SNPs),但数据质量常较差且验证研究少。

要点

  • 纳入69篇出版物,中位患者数81例,75%为男性,84%为III/IV期。
  • 最常研究的生物标志物为SNPs(59%)、唾液蛋白(13%)和细菌(10%)。
  • 低偏倚出版物中鉴定出10个有统计学意义的生物标志物,均为SNPs,涉及DNA修复和细胞解毒通路。

核心结论

  • 本综述概述了研究现状,指出了研究空白并为未来研究方向提供了建议。
  • 鉴定出若干潜在生物标志物,尤其涉及DNA修复通路,与当前对辐射诱导细胞损伤的理解一致。
  • 总体数据质量较差,关键临床变量常缺失。
  • 需要严格的报告标准化、验证研究和多中心合作以提高研究效能和样本量,从而为临床应用建立高级别证据。

研究设计与样本

  • 系统综述,两名评价员独立筛选EMBASE和PubMed 2010至2023年发表的文献。
  • 终点为皮炎、黏膜炎、黏稠唾液/口干和吞咽困难。
  • 使用R进行统计分析,通过改良QUIPS问卷评估偏倚,使用gProfiler进行通路分析。
  • 研究遵循PRISMA和COSMOS-E指南,并在PROSPERO数据库注册(#CRD42023361245)。

主要发现

  • 从2550篇摘要中纳入69篇出版物。
  • 研究涉及中位81例患者,主要为男性(75%),常见原发肿瘤为鼻咽(32%)和口咽(27%)。
  • 大多数患者(84%)为晚期疾病(III/IV期)。
  • 最常研究的生物标志物为DNA单核苷酸多态性(SNPs,59%)、唾液蛋白(13%)和细菌(10%)。
  • 在低偏倚出版物中鉴定出10个有统计学意义的生物标志物(均为SNPs),特别涉及DNA修复和细胞解毒通路。

关键数值与推荐

  • 数据质量常较差,数据集中验证研究少。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 数据质量常较差且数据集中验证研究少。
  • 关键临床变量常缺失。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Radiotherapy is essential for treating head and neck cancer but often leads to severe toxicity. Traditional predictors include anatomical location, tumor extent, and dosimetric data. Recently, biomarkers have been explored to better predict and understand toxicity. This review aims to summarize the current literature, assess data quality, and guide future research. METHODS: Two reviewers independently screened EMBASE and PubMed for studies published between 2010 and 2023. Endpoints were dermatitis, mucositis, sticky saliva/xerostomia, and dysphagia. Statistical analysis was performed using R, and bias assessed via a modified QUIPS questionnaire. Pathway analysis was conducted using gProfiler. The study adhered to PRISMA and COSMOS-E guidelines and was registered in the PROSPERO database (#CRD42023361245). RESULTS: Of 2,550 abstracts, 69 publications met the inclusion criteria. These studies involved a median of 81 patients, primarily male (75 %), with common primary tumors in the nasopharynx (32 %) and oropharynx (27 %). Most patients (84 %) had advanced disease (stage III/IV). The most frequently studied biomarkers were DNA-based single-nucleotide polymorphisms (SNPs, 59 %), salivary proteins (13 %), and bacteria (10 %). Ten statistically-significant biomarkers (all SNPs) in low-bias publications were identified, particularly in DNA repair and cell detoxification pathways. Data quality was often poor and few validation studies were present in the dataset. CONCLUSION: This review provides an overview of the research landscape, highlights research gaps and provides recommendations for future research directions. We identified several potential biomarkers, particularly in DNA repair pathways, that align with current understanding of radiation-induced cell damage. However, the overall data quality was poor, with key clinical variables often missing. Overall, rigorous standardization of reporting, validation studies and multi-center collaborations to increase study power and sample sizes are necessary to build high-level evidence for clinical application.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Koch A, Reinhardt P, Elicin O, et al. Predictive biomarkers of radiotherapy- related dermatitis, xerostomia, mucositis and dysphagia in head and neck cancer: A systematic review. Radiother Oncol. 2024. PMID: 39706342. doi:10.1016/j.radonc.2024.110689

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。